PDS Biotechnology Corporation (PDSB)

2Q23 Achieves Important Milestones With More To Follow


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
August 15, 2023
Report ID: 26055
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


PDS Biotechnology Corporation
PDS Biotechnology Corporation
Healthcare
Biotechnology
Ticker
PDSB
Current Price
$5.33 -9.66%
Market Cap
$165.8M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$3.8 - $13.65
Related Research Reports
11/15/2023

Clinical Milestones For 2024 Announced With 3Q23 Financial Results
Clinical Milestones For 2024 Announced With 3Q23 Financial Results (PDSB)
11/10/2023

Triple Therapy Data Shows Benefits That Far Exceed Published Studies
Triple Therapy Data Shows Benefits That Far Exceed Published Studies (PDSB)
10/12/2023

Data For PDS0301 Phase 1/2 To Show Immune Response and Safety Data
Data For PDS0301 Phase 1/2 To Show Immune Response and Safety Data (PDSB)
10/4/2023

Strong Phase 2 Survival Data, But Stock Sells Off Anyway
Strong Phase 2 Survival Data, But Stock Sells Off Anyway (PDSB)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.